Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Paxman AB (PXMBF) Stock Price & Analysis

PXMBF Stock Chart & Stats

$0.01$0.00(0.00%)
At close: 4:00 PM EDT
$2.5$51 Nov1 Feb1 May19 Jul19 Dec16 May
Day’s Range
$0.01 - $0.01
52-Week Range
$0.01 - $3.50
Previous Close
$0.01
Volume
330
Average Volume (3M)
0
Market Cap
$157.03M
Enterprise Value
$1.06B
Total Cash (Recent Filing)
$105.64M
Total Debt (Recent Filing)
$12.37M
Price to Earnings (P/E)
―
Beta
-0.14
Next Earnings
Nov 20, 2026 (Est.)
EPS Estimate
0.04
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth And Demand

Rapid sales growth and a sizeable order book indicate expanding adoption of scalp-cooling systems across treatment sites. This supports forward revenue visibility, strengthens the company’s market position, and provides a foundation for recurring consumables and service revenue.

Recurring Utilization Revenue Is Scaling

The insurance-based billing model is increasing treatment utilization and recurring cap revenue at installed sites. Higher usage per site and system can improve revenue productivity without requiring equivalent hardware growth, supporting a more durable commercial model.

Conservative Balance Sheet And Liquidity

Very low leverage limits financial risk and preserves flexibility for commercial expansion, product development, and integration efforts. The reported cash balance also provides a buffer while the company works to convert sales momentum into consistently positive earnings and cash generation.

Bears Say

Losses And Negative Cash Generation

Current losses and negative operating and free cash flow show that growth is not yet being funded by internal cash generation. If this persists, liquidity could be consumed more quickly and management may have less flexibility to finance expansion and product programs.

Neuropathy Device Regulatory Delay

The required De Novo pathway delays the neuropathy device and introduces greater approval uncertainty than the planned 510(k) route. Potential information or clinical-data requests could further defer commercialization, slowing the product’s contribution to future growth.

Cost Pressure Is Weakening Profitability

Higher operating and CIPN-related spending is reducing reported profitability while the company invests in expansion and regulatory work. Continued cost intensity could keep margins below their potential and delay the transition from strong revenue growth to durable earnings.

Paxman AB News

PXMBF FAQ

What was Paxman AB’s price range in the past 12 months?
Paxman AB lowest stock price was $0.01 and its highest was $3.50 in the past 12 months.
What is Paxman AB’s market cap?
Paxman AB’s market cap is $157.03M.
When is Paxman AB’s upcoming earnings report date?
Paxman AB’s next earnings report is estimated for Nov 20, 2026 (not yet confirmed), which is in 19 days.
How were Paxman AB’s earnings last quarter?
Paxman AB released its earnings results on Aug 21, 2026. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by -$0.02.
Is Paxman AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Paxman AB pay dividends?
Paxman AB does not currently pay dividends.
What is Paxman AB’s EPS estimate?
Paxman AB’s EPS estimate is 0.04.
How many shares outstanding does Paxman AB have?
Paxman AB has 23,273,417 shares outstanding.
What happened to Paxman AB’s price movement after its last earnings report?
Paxman AB reported an EPS of $0.01 in its last earnings report, missing expectations of $0.03. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Paxman AB?
Currently, no hedge funds are holding shares in PXMBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology